Regenxbio (RGNX) Non Operating Income (2014 - 2025)

Regenxbio's Non Operating Income history runs 12 years deep, the most recent figure standing at -$9.5 million for Q4 2025.

• In Q4 2025, Non Operating Income fell 5326.92% year-over-year to -$9.5 million; the TTM figure through Dec 2025 stood at -$32.7 million (down 623.38% YoY), while the FY2025 annual figure was -$32.7 million, down 623.38% from the prior year.
• Non Operating Income was -$9.5 million for Q4 2025 at Regenxbio, roughly flat from -$9.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.1 million in Q3 2023 to a low of -$9.5 million in Q3 2025.
• Historically, Non Operating Income has averaged -$2.9 million across 5 years, with a median of -$3.3 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income soared 202.7% in 2024, then slumped 5326.92% in 2025.
• A 5-year view of Non Operating Income shows it stood at -$6.2 million in 2021, then surged by 64.23% to -$2.2 million in 2022, then jumped by 139.06% to $862000.0 in 2023, then slumped by 78.89% to $182000.0 in 2024, then plunged by 5326.92% to -$9.5 million in 2025.
• The last three Non Operating Income figures came in at -$9.5 million (Q4 2025), -$9.5 million (Q3 2025), and -$7.6 million (Q2 2025), per Business Quant data.